K. Ryan

发表

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

F. Gleeson, M. Carroll, H. Humphries, 2021, Vaccine.

Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19

A. Nicholson, F. Gleeson, C. Turner, 2020, bioRxiv.

Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza

M. Carroll, P. Yeates, A. Marriott, 2019, Scientific Reports.

Dopamine Receptors on Adrenal Chromaffin Cells Modulate Calcium Uptake and Catecholamine Release

A. S. Schneider, D. Napp, M. Suozzo, 1988, Journal of neurochemistry.

Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung

M. Carroll, N. Silman, A. Marriott, 2018, PloS one.

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine

M. Carroll, B. Hallis, A. Marriott, 2021, npj Vaccines.

Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques

Q. Sattentau, F. Gleeson, R. Russell, 2020, bioRxiv.

DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model

R. De Francesco, F. Palombo, M. Iannacone, 2022, Vaccines.

Sequential delivery of LAIV and SARS-CoV-2 in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology

M. Carroll, F. Salguero, A. Marriott, 2021, bioRxiv.

Selective Inactivation of Eukaryotic β-Galactosidase in Assays for Inhibitors of HIV-1 TAT Using Bacterial β-Galactosidase as a Reporter Enzyme

D. Young, F. Dutko, K. Ryan, 1993 .

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Amy C. Thomas, D. Rice, V. Libri, 2021, The Lancet.

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

F. Gleeson, M. Carroll, H. Humphries, 2020, bioRxiv.

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization.

D. Young, J. Hughes, W. Michne, 1995, Journal of medicinal chemistry.

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques

Q. Sattentau, R. Russell, M. Carroll, 2021, Science advances.

Comparative pathogenesis of influenza in ferrets

K. Ryan, 2020 .

Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection

J. Stewart, M. Carroll, J. Hiscox, 2016, PloS one.

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

C. Turner, M. Carroll, J. Hiscox, 2021, Nature Communications.

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models

G. Ciliberto, C. Castilletti, M. Capobianchi, 2021, Molecular Therapy.

COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19

G. Ciliberto, G. Ippolito, C. Castilletti, 2021, bioRxiv.

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

D. Jackson, W. Zeng, M. Carroll, 2020, bioRxiv.

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

M. Carroll, D. Bailey, H. Humphries, 2021, Communications Biology.

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

A. Nicholson, F. Gleeson, A. Darby, 2021, Nature Communications.

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

F. Gleeson, M. Carroll, D. Bailey, 2021, Communications biology.

Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model

J. McKeating, F. Issa, M. Carroll, 2022, bioRxiv.

Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain

S. Pimplikar, K. Ryan, 2005, The Journal of cell biology.

Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir

W. Barclay, M. Carroll, N. Dimmock, 2014, PloS one.

Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant

D. Morley, R. Vipond, S. Funnell, 2021, bioRxiv.

Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection

I. Brown, H. Simmons, M. Carroll, 2021, Viruses.

Selective inactivation of eukaryotic beta-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial beta-galactosidase as a reporter enzyme.

D. Young, F. Dutko, K. Ryan, 1993, Analytical biochemistry.

Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza

M. Carroll, P. Yeates, A. Marriott, 2019, Scientific Reports.

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant

Richard R. Hesp, D. Morley, R. Vipond, 2023, PLoS pathogens.

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum

S. Funnell, N. Coombes, K. Bewley, 2023, Viruses.

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

C. Turner, M. Carroll, J. Hiscox, 2021, Nature Communications.

Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge

M. Carroll, J. Hiscox, H. Humphries, 2020, bioRxiv.

Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein

D. Montefiori, D. Bolognesi, M. Murphey-Corb, 1994, Journal of virology.

Infection with Seasonal H1N1 Influenza Results in Comparable Disease Kinetics and Host Immune Responses in Ferrets and Golden Syrian Hamsters

D. Morley, F. Salguero, P. Yeates, 2023, Pathogens.

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum

S. Funnell, N. Coombes, K. Bewley, 2023, Viruses.